CA2931219A1 - Piperidine compounds having multimodal activity against pain - Google Patents
Piperidine compounds having multimodal activity against pain Download PDFInfo
- Publication number
- CA2931219A1 CA2931219A1 CA2931219A CA2931219A CA2931219A1 CA 2931219 A1 CA2931219 A1 CA 2931219A1 CA 2931219 A CA2931219 A CA 2931219A CA 2931219 A CA2931219 A CA 2931219A CA 2931219 A1 CA2931219 A1 CA 2931219A1
- Authority
- CA
- Canada
- Prior art keywords
- substituted
- unsubstituted
- methyl
- phenyl
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13384005 | 2013-12-20 | ||
| EP13384005.8 | 2013-12-20 | ||
| PCT/EP2014/078811 WO2015091988A1 (en) | 2013-12-20 | 2014-12-19 | Piperidine compounds having multimodal activity against pain |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2931219A1 true CA2931219A1 (en) | 2015-06-25 |
Family
ID=49998041
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2931219A Abandoned CA2931219A1 (en) | 2013-12-20 | 2014-12-19 | Piperidine compounds having multimodal activity against pain |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US9902711B2 (enExample) |
| EP (1) | EP3083595B1 (enExample) |
| JP (1) | JP6498672B2 (enExample) |
| CN (1) | CN105829297B (enExample) |
| CA (1) | CA2931219A1 (enExample) |
| ES (1) | ES2806408T3 (enExample) |
| MX (1) | MX2016006603A (enExample) |
| WO (1) | WO2015091988A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2017502010A (ja) | 2013-12-20 | 2017-01-19 | ラボラトリオス・デル・デエレ・エステベ・エセ・ア | 疼痛に対して多重モードの活性を有するピペリジン誘導体 |
| CN107001368B (zh) * | 2014-11-21 | 2019-05-31 | 埃斯特韦制药股份公司 | 具有多重模式抗疼痛活性的1,9-二氮杂螺环十一烷化合物 |
| MX2018000419A (es) * | 2015-07-29 | 2018-05-07 | Esteve Labor Dr | Derivados de amida sustituida que tienen actividad multimodal contra el dolor. |
| TW201734009A (zh) * | 2015-10-23 | 2017-10-01 | 艾斯提夫博士實驗股份有限公司 | 具有抗疼痛活性的經取代的□啉衍生物 |
| TW202304448A (zh) * | 2021-04-07 | 2023-02-01 | 西班牙商塔拉森斯調節公司 | 作為西格瑪配位基的新(高)哌啶基雜環 |
| WO2024105225A1 (en) | 2022-11-18 | 2024-05-23 | Universitat De Barcelona | Synergistic combinations of a sigma receptor 1 (s1r) antagonist and a soluble epoxide hydrolase inhibitor (sehi) and their use in the treatment of pain |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2083476B (en) * | 1980-09-12 | 1984-02-08 | Wyeth John & Brother Ltd | Heterocyclic compounds |
| ZA871335B (en) * | 1986-02-27 | 1987-09-30 | Duphar Int Res | New aryl-substituted(n-piperidinyl)methyl-and(n-piperazinyl)-methylazoles having antipsychotic properties |
| US5681956A (en) * | 1990-12-28 | 1997-10-28 | Neurogen Corporation | 4-aryl substituted piperazinylmethyl phenylimidazole derivatives; a new class of dopamine receptor subtype specific ligands |
| DE4321366A1 (de) * | 1993-06-26 | 1995-01-05 | Merck Patent Gmbh | Piperidine und Piperazine |
| EP1053235A1 (en) * | 1998-02-03 | 2000-11-22 | American Home Products Corporation | Oxazole derivatives as serotonin-1a receptor agonists |
| US6248755B1 (en) * | 1999-04-06 | 2001-06-19 | Merck & Co., Inc. | Pyrrolidine modulators of chemokine receptor activity |
| GB9912411D0 (en) * | 1999-05-28 | 1999-07-28 | Pfizer Ltd | Compounds useful in therapy |
| GB9912410D0 (en) * | 1999-05-28 | 1999-07-28 | Pfizer Ltd | Compounds useful in therapy |
| GB9912415D0 (en) * | 1999-05-28 | 1999-07-28 | Pfizer Ltd | Compounds useful in therapy |
| JP3893960B2 (ja) * | 2001-01-12 | 2007-03-14 | トヨタ自動車株式会社 | 動力伝達装置 |
| EP1648881A1 (en) * | 2003-07-04 | 2006-04-26 | GlaxoSmithKline S.p.A. | Substituted indole ligands for the orl-1 receptor |
| JP4761756B2 (ja) * | 2003-10-31 | 2011-08-31 | 大塚製薬株式会社 | 2,3−ジヒドロイミダゾ[2,1−b]オキサゾ−ル化合物 |
| WO2008157844A1 (en) | 2007-06-21 | 2008-12-24 | Forest Laboratories Holdings Limited | Novel piperazine derivatives as inhibitors of stearoyl-coa desaturase |
| WO2010046780A2 (en) | 2008-10-22 | 2010-04-29 | Institut Pasteur Korea | Anti viral compounds |
| WO2010080864A1 (en) | 2009-01-12 | 2010-07-15 | Array Biopharma Inc. | Piperidine-containing compounds and use thereof |
| WO2011072275A2 (en) * | 2009-12-11 | 2011-06-16 | Nono, Inc. | Agents and methods for treating ischemic and other diseases |
| NZ602368A (en) | 2010-02-12 | 2014-10-31 | Pharmascience Inc | Iap bir domain binding compounds |
| WO2011137331A2 (en) * | 2010-04-30 | 2011-11-03 | Kinentia Biosciences Llc | 4-fluoro-4-arylpiperdin-1-yl derivatives as mu opioid function moderators |
| JP2013189395A (ja) * | 2012-03-14 | 2013-09-26 | Dainippon Sumitomo Pharma Co Ltd | ジヒドロピロロピラジノン誘導体 |
| JP2016028016A (ja) * | 2012-12-12 | 2016-02-25 | 大日本住友製薬株式会社 | オキサジアゾール誘導体とその医薬用途 |
-
2014
- 2014-12-19 CA CA2931219A patent/CA2931219A1/en not_active Abandoned
- 2014-12-19 EP EP14816259.7A patent/EP3083595B1/en active Active
- 2014-12-19 CN CN201480070014.9A patent/CN105829297B/zh not_active Expired - Fee Related
- 2014-12-19 US US15/106,398 patent/US9902711B2/en not_active Expired - Fee Related
- 2014-12-19 MX MX2016006603A patent/MX2016006603A/es unknown
- 2014-12-19 JP JP2016539898A patent/JP6498672B2/ja not_active Expired - Fee Related
- 2014-12-19 WO PCT/EP2014/078811 patent/WO2015091988A1/en not_active Ceased
- 2014-12-19 ES ES14816259T patent/ES2806408T3/es active Active
Also Published As
| Publication number | Publication date |
|---|---|
| WO2015091988A1 (en) | 2015-06-25 |
| JP6498672B2 (ja) | 2019-04-10 |
| US20170001979A1 (en) | 2017-01-05 |
| JP2016540793A (ja) | 2016-12-28 |
| CN105829297A (zh) | 2016-08-03 |
| EP3083595B1 (en) | 2020-05-27 |
| MX2016006603A (es) | 2016-09-06 |
| EP3083595A1 (en) | 2016-10-26 |
| ES2806408T3 (es) | 2021-02-17 |
| CN105829297B (zh) | 2019-08-09 |
| US9902711B2 (en) | 2018-02-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10745361B2 (en) | Piperazine derivatives having multimodal activity against pain | |
| JP6535687B2 (ja) | 疼痛に対する多様な活性を有する1−オキサ−4,9−ジアザスピロウンデカン化合物のアルキルおよびアリール誘導体 | |
| JP6611736B2 (ja) | 疼痛に対する多様な活性を有する1−オキサ−4,9−ジアザスピロウンデカン化合物のアルキル誘導体 | |
| EP3083601B1 (en) | Piperidine derivatives having multimodal activity against pain | |
| JP6516773B2 (ja) | 疼痛に対する多様な活性を有する1−オキサ−4,9−ジアザスピロウンデカン化合物のアミド誘導体 | |
| WO2017178515A1 (en) | Piperidinylalkylamide derivatives having multimodal activity against pain | |
| CA2931219A1 (en) | Piperidine compounds having multimodal activity against pain | |
| JP2017535566A (ja) | 疼痛に対する多様な活性を有する1,9−ジアザスピロウンデカン化合物 | |
| EP3458450B1 (en) | Tetrahydropyran derivatives having multimodal activity against pain | |
| US10189828B2 (en) | 1-methylpyrazole-piperazine compounds having multimodal activity against pain | |
| EP3328847B1 (en) | N-(2-(3-(benzyl(methyl)amino)pyrrolidin-1-yl)ethyl)-n-phenyl)propionamide derivatives and related compounds as dual sigma 1 and mu opioid receptor ligands for the treatment of pain | |
| WO2018153545A1 (en) | Piperidine methanone derivatives having multimodal activity against pain | |
| WO2018153546A1 (en) | Tetrahydropyran and tetrahydrothiopyran methanone derivatives having multimodal activity against pain | |
| WO2018108319A1 (en) | Tetrahydropyran and tetrahydrothiopyran amide derivatives having multimodal activity against pain | |
| TW201627301A (zh) | 具有抗疼痛之多重模式活性的哌啶化合物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued |
Effective date: 20210309 |
|
| FZDE | Discontinued |
Effective date: 20210309 |